Related Experiment Video

Updated: Aug 24, 2026

Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma
06:15

Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma

Published on: October 27, 2014

Maximizing the potential of bevacizumab in cancer treatment

Emily Bergsland1, Maura N Dickler

  • 1Department of Medicine, University of California, San Francisco, California 94115, USA. emilyb@medicine.ucsf.edu

The Oncologist
|June 5, 2004
PubMed

Insights

Bevacizumab shows promise in solid tumors, but further research is needed to optimize its use. Understanding its mechanism and resistance pathways is key to maximizing its clinical benefit.

Area of Science:

  • Oncology
  • Pharmacology

Background:

  • Bevacizumab (Avastin) has demonstrated promising results in clinical trials for various solid tumors.
  • Further research is essential to fully realize the therapeutic potential of bevacizumab.

Purpose of the Study:

  • To identify key areas for further investigation regarding bevacizumab's clinical application.
  • To explore strategies for optimizing bevacizumab dosage, combination therapies, toxicity management, and patient selection.

Main Methods:

  • Review of clinical trial data and existing literature on bevacizumab.
  • Analysis of outcomes from two recent phase III trials involving bevacizumab.

Main Results:

  • Bevacizumab has shown efficacy in treating a range of solid tumors.
  • Recent phase III trials underscore the need for refined clinical integration strategies for bevacizumab.

Conclusions:

  • Optimization of bevacizumab dosage, administration schedule, and combination with chemotherapy/radiation is required.
  • A deeper understanding of bevacizumab's mechanism of action and resistance pathways is crucial for maximizing patient benefit and clinical utility.

More Related Videos

Three-dimensional Angiogenesis Assay System using Co-culture Spheroids Formed by Endothelial Colony Forming Cells and Mesenchymal Stem Cells09:24

Three-dimensional Angiogenesis Assay System using Co-culture Spheroids Formed by Endothelial Colony Forming Cells and Mesenchymal Stem Cells

Published on: September 18, 2019

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...